Flavin Lisa 4

What Happened

• Lisa Flavin, a director of Caleres, received an award of 12,196 restricted stock units (RSUs) on June 8, 2026. The grant is reported at a per-share fair value of $13.12, for a total reported value of $160,012. The transaction is coded as an award/grant (A) and is a derivative award rather than an open-market purchase.

Key Details

• Transaction date and filing: Grant made 2026-06-08; Form 4 filed 2026-06-10 (timely within the standard two-business-day reporting window).
• Price/value: $13.12 per share (reported fair market value); total reported value $160,012.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 — Each RSU represents a contingent right to receive the fair market value of one share. F2 — Vesting is contingent on Flavin’s continued service through the next annual meeting; RSUs will be settled in shares when her director service terminates or on another date she may elect.
• Transaction code: A = Award/Grant (derivative), not a purchase or sale.

Context

• These RSUs are a form of director compensation and are contingent on continued service; they do not represent an immediate open-market purchase of shares. Settlement will convert the RSUs into shares (or value) later per the plan’s terms, so this grant increases potential future ownership but does not immediately change the company’s outstanding share count. Such grants are routine for directors and should be viewed as compensation rather than a direct market vote.